1 Human Embryonic Stem Cells (HESC) Market Overview 1.1 Product Overview and Scope of Human Embryonic Stem Cells (HESC) 1.2 Human Embryonic Stem Cells (HESC) Segment by Type 1.2.1 Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Type (2023-2029) 1.2.2 Totipotent Stem Cells 1.2.3 Pluripotent Stem Cells 1.2.4 Unipotent Stem Cells 1.3 Human Embryonic Stem Cells (HESC) Segment by Application 1.3.1 Global Human Embryonic Stem Cells (HESC) Market Value by Application: (2023-2029) 1.3.2 Research 1.3.3 Clinical Trials 1.3.4 Others 1.4 Global Human Embryonic Stem Cells (HESC) Market Size Estimates and Forecasts 1.4.1 Global Human Embryonic Stem Cells (HESC) Revenue 2018-2029 1.4.2 Global Human Embryonic Stem Cells (HESC) Sales 2018-2029 1.4.3 Global Human Embryonic Stem Cells (HESC) Market Average Price (2018-2029) 1.5 Assumptions and Limitations 2 Human Embryonic Stem Cells (HESC) Market Competition by Manufacturers 2.1 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers (2018-2023) 2.2 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Manufacturers (2018-2023) 2.3 Global Human Embryonic Stem Cells (HESC) Average Price by Manufacturers (2018-2023) 2.4 Global Human Embryonic Stem Cells (HESC) Industry Ranking 2021 VS 2022 VS 2023 2.5 Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Product Type & Application 2.7 Human Embryonic Stem Cells (HESC) Market Competitive Situation and Trends 2.7.1 Human Embryonic Stem Cells (HESC) Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Human Embryonic Stem Cells (HESC) Players Market Share by Revenue 2.7.3 Global Human Embryonic Stem Cells (HESC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Human Embryonic Stem Cells (HESC) Retrospective Market Scenario by Region 3.1 Global Human Embryonic Stem Cells (HESC) Market Size by Region: 2018 Versus 2022 Versus 2029 3.2 Global Human Embryonic Stem Cells (HESC) Global Human Embryonic Stem Cells (HESC) Sales by Region: 2018-2029 3.2.1 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2018-2023 3.2.2 Global Human Embryonic Stem Cells (HESC) Sales by Region: 2024-2029 3.3 Global Human Embryonic Stem Cells (HESC) Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2018-2029 3.3.1 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2018-2023 3.3.2 Global Human Embryonic Stem Cells (HESC) Revenue by Region: 2024-2029 3.4 North America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country 3.4.1 North America Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029 3.4.2 North America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029) 3.4.3 North America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country 3.5.1 Europe Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029 3.5.2 Europe Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029) 3.5.3 Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country 3.6.1 Asia Pacific Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029 3.6.2 Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029) 3.6.3 Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country 3.7.1 Latin America Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029 3.7.2 Latin America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029) 3.7.3 Latin America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Facts & Figures by Country 3.8.1 Middle East and Africa Human Embryonic Stem Cells (HESC) Market Size by Country: 2018 VS 2022 VS 2029 3.8.2 Middle East and Africa Human Embryonic Stem Cells (HESC) Sales by Country (2018-2029) 3.8.3 Middle East and Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2029) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 UAE 4 Segment by Type 4.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2018-2029) 4.1.1 Global Human Embryonic Stem Cells (HESC) Sales by Type (2018-2023) 4.1.2 Global Human Embryonic Stem Cells (HESC) Sales by Type (2024-2029) 4.1.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2018-2029) 4.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2018-2029) 4.2.1 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2018-2023) 4.2.2 Global Human Embryonic Stem Cells (HESC) Revenue by Type (2024-2029) 4.2.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2018-2029) 4.3 Global Human Embryonic Stem Cells (HESC) Price by Type (2018-2029) 5 Segment by Application 5.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2018-2029) 5.1.1 Global Human Embryonic Stem Cells (HESC) Sales by Application (2018-2023) 5.1.2 Global Human Embryonic Stem Cells (HESC) Sales by Application (2024-2029) 5.1.3 Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2018-2029) 5.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2018-2029) 5.2.1 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2018-2023) 5.2.2 Global Human Embryonic Stem Cells (HESC) Revenue by Application (2024-2029) 5.2.3 Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2018-2029) 5.3 Global Human Embryonic Stem Cells (HESC) Price by Application (2018-2029) 6 Key Companies Profiled 6.1 ESI BIO 6.1.1 ESI BIO Corporation Information 6.1.2 ESI BIO Description and Business Overview 6.1.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.1.4 ESI BIO Human Embryonic Stem Cells (HESC) Product Portfolio 6.1.5 ESI BIO Recent Developments/Updates 6.2 Thermo Fisher 6.2.1 Thermo Fisher Corporation Information 6.2.2 Thermo Fisher Description and Business Overview 6.2.3 Thermo Fisher Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.2.4 Thermo Fisher Human Embryonic Stem Cells (HESC) Product Portfolio 6.2.5 Thermo Fisher Recent Developments/Updates 6.3 BioTime 6.3.1 BioTime Corporation Information 6.3.2 BioTime Description and Business Overview 6.3.3 BioTime Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.3.4 BioTime Human Embryonic Stem Cells (HESC) Product Portfolio 6.3.5 BioTime Recent Developments/Updates 6.4 MilliporeSigma (Merck) 6.4.1 MilliporeSigma (Merck) Corporation Information 6.4.2 MilliporeSigma (Merck) Description and Business Overview 6.4.3 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.4.4 MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Portfolio 6.4.5 MilliporeSigma (Merck) Recent Developments/Updates 6.5 BD Biosciences 6.5.1 BD Biosciences Corporation Information 6.5.2 BD Biosciences Description and Business Overview 6.5.3 BD Biosciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.5.4 BD Biosciences Human Embryonic Stem Cells (HESC) Product Portfolio 6.5.5 BD Biosciences Recent Developments/Updates 6.6 Astellas Institute of Regenerative Medicine 6.6.1 Astellas Institute of Regenerative Medicine Corporation Information 6.6.2 Astellas Institute of Regenerative Medicine Description and Business Overview 6.6.3 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.6.4 Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Portfolio 6.6.5 Astellas Institute of Regenerative Medicine Recent Developments/Updates 6.7 Asterias Biotherapeutics 6.6.1 Asterias Biotherapeutics Corporation Information 6.6.2 Asterias Biotherapeutics Description and Business Overview 6.6.3 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.4.4 Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Portfolio 6.7.5 Asterias Biotherapeutics Recent Developments/Updates 6.8 PerkinElmer 6.8.1 PerkinElmer Corporation Information 6.8.2 PerkinElmer Description and Business Overview 6.8.3 PerkinElmer Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.8.4 PerkinElmer Human Embryonic Stem Cells (HESC) Product Portfolio 6.8.5 PerkinElmer Recent Developments/Updates 6.9 Takara Bio 6.9.1 Takara Bio Corporation Information 6.9.2 Takara Bio Description and Business Overview 6.9.3 Takara Bio Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.9.4 Takara Bio Human Embryonic Stem Cells (HESC) Product Portfolio 6.9.5 Takara Bio Recent Developments/Updates 6.10 Fujifilm Cellular Dynamics 6.10.1 Fujifilm Cellular Dynamics Corporation Information 6.10.2 Fujifilm Cellular Dynamics Description and Business Overview 6.10.3 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.10.4 Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Portfolio 6.10.5 Fujifilm Cellular Dynamics Recent Developments/Updates 6.11 Reliance Life Sciences 6.11.1 Reliance Life Sciences Corporation Information 6.11.2 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Description and Business Overview 6.11.3 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.11.4 Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Portfolio 6.11.5 Reliance Life Sciences Recent Developments/Updates 6.12 R&D Systems (Biotrchne) 6.12.1 R&D Systems (Biotrchne) Corporation Information 6.12.2 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Description and Business Overview 6.12.3 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.12.4 R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Portfolio 6.12.5 R&D Systems (Biotrchne) Recent Developments/Updates 6.13 STEMCELL Technologies 6.13.1 STEMCELL Technologies Corporation Information 6.13.2 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Description and Business Overview 6.13.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.13.4 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Portfolio 6.13.5 STEMCELL Technologies Recent Developments/Updates 6.14 TATAA Biocenter 6.14.1 TATAA Biocenter Corporation Information 6.14.2 TATAA Biocenter Human Embryonic Stem Cells (HESC) Description and Business Overview 6.14.3 TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.14.4 TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Portfolio 6.14.5 TATAA Biocenter Recent Developments/Updates 6.15 UK Stem Cell Bank 6.15.1 UK Stem Cell Bank Corporation Information 6.15.2 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Description and Business Overview 6.15.3 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.15.4 UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Portfolio 6.15.5 UK Stem Cell Bank Recent Developments/Updates 6.16 Viacyte, Inc. 6.16.1 Viacyte, Inc. Corporation Information 6.16.2 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Description and Business Overview 6.16.3 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales, Revenue and Gross Margin (2018-2023) 6.16.4 Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Portfolio 6.16.5 Viacyte, Inc. Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Human Embryonic Stem Cells (HESC) Industry Chain Analysis 7.2 Human Embryonic Stem Cells (HESC) Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Human Embryonic Stem Cells (HESC) Production Mode & Process 7.4 Human Embryonic Stem Cells (HESC) Sales and Marketing 7.4.1 Human Embryonic Stem Cells (HESC) Sales Channels 7.4.2 Human Embryonic Stem Cells (HESC) Distributors 7.5 Human Embryonic Stem Cells (HESC) Customers 8 Human Embryonic Stem Cells (HESC) Market Dynamics 8.1 Human Embryonic Stem Cells (HESC) Industry Trends 8.2 Human Embryonic Stem Cells (HESC) Market Drivers 8.3 Human Embryonic Stem Cells (HESC) Market Challenges 8.4 Human Embryonic Stem Cells (HESC) Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer

List of Tables Table 1. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Type (2023-2029) & (US$ Million) Table 2. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Application (2023-2029) & (US$ Million) Table 3. Global Human Embryonic Stem Cells (HESC) Market Competitive Situation by Manufacturers in 2022 Table 4. Global Human Embryonic Stem Cells (HESC) Sales (K Units) of Key Manufacturers (2018-2023) Table 5. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Manufacturers (2018-2023) Table 6. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Manufacturers (2018-2023) Table 7. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers (2018-2023) Table 8. Global Market Human Embryonic Stem Cells (HESC) Average Price (USD/Unit) of Key Manufacturers (2018-2023) Table 9. Global Key Players of Human Embryonic Stem Cells (HESC), Industry Ranking, 2021 VS 2022 VS 2023 Table 10. Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Product Type & Application Table 12. Global Key Manufacturers of Human Embryonic Stem Cells (HESC), Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Human Embryonic Stem Cells (HESC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Embryonic Stem Cells (HESC) as of 2022) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 17. Global Human Embryonic Stem Cells (HESC) Sales by Region (2018-2023) & (K Units) Table 18. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2018-2023) Table 19. Global Human Embryonic Stem Cells (HESC) Sales by Region (2024-2029) & (K Units) Table 20. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2024-2029) Table 21. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2018-2023) & (US$ Million) Table 22. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2018-2023) Table 23. Global Human Embryonic Stem Cells (HESC) Revenue by Region (2024-2029) & (US$ Million) Table 24. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2024-2029) Table 25. North America Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 26. North America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units) Table 27. North America Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units) Table 28. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million) Table 29. North America Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million) Table 30. Europe Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 31. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units) Table 32. Europe Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units) Table 33. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million) Table 34. Europe Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million) Table 35. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million) Table 36. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Region (2018-2023) & (K Units) Table 37. Asia Pacific Human Embryonic Stem Cells (HESC) Sales by Region (2024-2029) & (K Units) Table 38. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2018-2023) & (US$ Million) Table 39. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue by Region (2024-2029) & (US$ Million) Table 40. Latin America Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 41. Latin America Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units) Table 42. Latin America Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units) Table 43. Latin America Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million) Table 44. Latin America Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million) Table 46. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Country (2018-2023) & (K Units) Table 47. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales by Country (2024-2029) & (K Units) Table 48. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue by Country (2024-2029) & (US$ Million) Table 50. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Type (2018-2023) Table 51. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Type (2024-2029) Table 52. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2018-2023) Table 53. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Type (2024-2029) Table 54. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Type (2018-2023) Table 55. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Type (2024-2029) Table 56. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2018-2023) Table 57. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Type (2024-2029) Table 58. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Type (2018-2023) Table 59. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Type (2024-2029) Table 60. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Application (2018-2023) Table 61. Global Human Embryonic Stem Cells (HESC) Sales (K Units) by Application (2024-2029) Table 62. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2018-2023) Table 63. Global Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2024-2029) Table 64. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Application (2018-2023) Table 65. Global Human Embryonic Stem Cells (HESC) Revenue (US$ Million) by Application (2024-2029) Table 66. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2018-2023) Table 67. Global Human Embryonic Stem Cells (HESC) Revenue Market Share by Application (2024-2029) Table 68. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Application (2018-2023) Table 69. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Application (2024-2029) Table 70. ESI BIO Corporation Information Table 71. ESI BIO Description and Business Overview Table 72. ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 73. ESI BIO Human Embryonic Stem Cells (HESC) Product Table 74. ESI BIO Recent Developments/Updates Table 75. Thermo Fisher Corporation Information Table 76. Thermo Fisher Description and Business Overview Table 77. Thermo Fisher Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 78. Thermo Fisher Human Embryonic Stem Cells (HESC) Product Table 79. Thermo Fisher Recent Developments/Updates Table 80. BioTime Corporation Information Table 81. BioTime Description and Business Overview Table 82. BioTime Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 83. BioTime Human Embryonic Stem Cells (HESC) Product Table 84. BioTime Recent Developments/Updates Table 85. MilliporeSigma (Merck) Corporation Information Table 86. MilliporeSigma (Merck) Description and Business Overview Table 87. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 88. MilliporeSigma (Merck) Human Embryonic Stem Cells (HESC) Product Table 89. MilliporeSigma (Merck) Recent Developments/Updates Table 90. BD Biosciences Corporation Information Table 91. BD Biosciences Description and Business Overview Table 92. BD Biosciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 93. BD Biosciences Human Embryonic Stem Cells (HESC) Product Table 94. BD Biosciences Recent Developments/Updates Table 95. Astellas Institute of Regenerative Medicine Corporation Information Table 96. Astellas Institute of Regenerative Medicine Description and Business Overview Table 97. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 98. Astellas Institute of Regenerative Medicine Human Embryonic Stem Cells (HESC) Product Table 99. Astellas Institute of Regenerative Medicine Recent Developments/Updates Table 100. Asterias Biotherapeutics Corporation Information Table 101. Asterias Biotherapeutics Description and Business Overview Table 102. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 103. Asterias Biotherapeutics Human Embryonic Stem Cells (HESC) Product Table 104. Asterias Biotherapeutics Recent Developments/Updates Table 105. PerkinElmer Corporation Information Table 106. PerkinElmer Description and Business Overview Table 107. PerkinElmer Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 108. PerkinElmer Human Embryonic Stem Cells (HESC) Product Table 109. PerkinElmer Recent Developments/Updates Table 110. Takara Bio Corporation Information Table 111. Takara Bio Description and Business Overview Table 112. Takara Bio Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 113. Takara Bio Human Embryonic Stem Cells (HESC) Product Table 114. Takara Bio Recent Developments/Updates Table 115. Fujifilm Cellular Dynamics Corporation Information Table 116. Fujifilm Cellular Dynamics Description and Business Overview Table 117. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 118. Fujifilm Cellular Dynamics Human Embryonic Stem Cells (HESC) Product Table 119. Fujifilm Cellular Dynamics Recent Developments/Updates Table 120. Reliance Life Sciences Corporation Information Table 121. Reliance Life Sciences Description and Business Overview Table 122. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 123. Reliance Life Sciences Human Embryonic Stem Cells (HESC) Product Table 124. Reliance Life Sciences Recent Developments/Updates Table 125. R&D Systems (Biotrchne) Corporation Information Table 126. R&D Systems (Biotrchne) Description and Business Overview Table 127. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 128. R&D Systems (Biotrchne) Human Embryonic Stem Cells (HESC) Product Table 129. R&D Systems (Biotrchne) Recent Developments/Updates Table 130. STEMCELL Technologies Corporation Information Table 131. STEMCELL Technologies Description and Business Overview Table 132. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 133. STEMCELL Technologies Human Embryonic Stem Cells (HESC) Product Table 134. STEMCELL Technologies Recent Developments/Updates Table 135. TATAA Biocenter Corporation Information Table 136. TATAA Biocenter Description and Business Overview Table 137. TATAA Biocenter Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 138. TATAA Biocenter Human Embryonic Stem Cells (HESC) Product Table 139. TATAA Biocenter Recent Developments/Updates Table 140. UK Stem Cell Bank Corporation Information Table 141. UK Stem Cell Bank Description and Business Overview Table 142. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 143. UK Stem Cell Bank Human Embryonic Stem Cells (HESC) Product Table 144. UK Stem Cell Bank Recent Developments/Updates Table 145. Viacyte, Inc. Corporation Information Table 146. Viacyte, Inc. Description and Business Overview Table 147. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) Table 148. Viacyte, Inc. Human Embryonic Stem Cells (HESC) Product Table 149. Viacyte, Inc. Recent Developments/Updates Table 150. Key Raw Materials Lists Table 151. Raw Materials Key Suppliers Lists Table 152. Human Embryonic Stem Cells (HESC) Distributors List Table 153. Human Embryonic Stem Cells (HESC) Customers List Table 154. Human Embryonic Stem Cells (HESC) Market Trends Table 155. Human Embryonic Stem Cells (HESC) Market Drivers Table 156. Human Embryonic Stem Cells (HESC) Market Challenges Table 157. Human Embryonic Stem Cells (HESC) Market Restraints Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Human Embryonic Stem Cells (HESC) Figure 2. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Type (2023-2029) & (US$ Million) Figure 3. Global Human Embryonic Stem Cells (HESC) Market Share by Type in 2022 & 2029 Figure 4. Totipotent Stem Cells Product Picture Figure 5. Pluripotent Stem Cells Product Picture Figure 6. Unipotent Stem Cells Product Picture Figure 7. Global Human Embryonic Stem Cells (HESC) Market Value Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Human Embryonic Stem Cells (HESC) Market Share by Application in 2022 & 2029 Figure 9. Research Figure 10. Clinical Trials Figure 11. Others Figure 12. Global Human Embryonic Stem Cells (HESC) Revenue, (US$ Million), 2018 VS 2022 VS 2029 Figure 13. Global Human Embryonic Stem Cells (HESC) Market Size (2018-2029) & (US$ Million) Figure 14. Global Human Embryonic Stem Cells (HESC) Sales (2018-2029) & (K Units) Figure 15. Global Human Embryonic Stem Cells (HESC) Average Price (USD/Unit) & (2018-2029) Figure 16. Human Embryonic Stem Cells (HESC) Report Years Considered Figure 17. Human Embryonic Stem Cells (HESC) Sales Share by Manufacturers in 2022 Figure 18. Global Human Embryonic Stem Cells (HESC) Revenue Share by Manufacturers in 2022 Figure 19. The Global 5 and 10 Largest Human Embryonic Stem Cells (HESC) Players: Market Share by Revenue in 2022 Figure 20. Human Embryonic Stem Cells (HESC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 21. Global Human Embryonic Stem Cells (HESC) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Figure 22. North America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029) Figure 23. North America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029) Figure 24. U.S. Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 25. Canada Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 26. Europe Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029) Figure 27. Europe Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029) Figure 28. Germany Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 29. France Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 30. U.K. Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 31. Italy Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 32. Russia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 33. Asia Pacific Human Embryonic Stem Cells (HESC) Sales Market Share by Region (2018-2029) Figure 34. Asia Pacific Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2018-2029) Figure 35. China Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 36. Japan Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 37. South Korea Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 38. India Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 39. Australia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 40. Taiwan Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 41. Indonesia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 42. Thailand Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 43. Malaysia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 44. Philippines Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 45. Latin America Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029) Figure 46. Latin America Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029) Figure 47. Mexico Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 48. Brazil Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 49. Argentina Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 50. Middle East & Africa Human Embryonic Stem Cells (HESC) Sales Market Share by Country (2018-2029) Figure 51. Middle East & Africa Human Embryonic Stem Cells (HESC) Revenue Market Share by Country (2018-2029) Figure 52. Turkey Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 53. Saudi Arabia Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 54. UAE Human Embryonic Stem Cells (HESC) Revenue Growth Rate (2018-2029) & (US$ Million) Figure 55. Global Sales Market Share of Human Embryonic Stem Cells (HESC) by Type (2018-2029) Figure 56. Global Revenue Market Share of Human Embryonic Stem Cells (HESC) by Type (2018-2029) Figure 57. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Type (2018-2029) Figure 58. Global Sales Market Share of Human Embryonic Stem Cells (HESC) by Application (2018-2029) Figure 59. Global Revenue Market Share of Human Embryonic Stem Cells (HESC) by Application (2018-2029) Figure 60. Global Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Application (2018-2029) Figure 61. Human Embryonic Stem Cells (HESC) Value Chain Figure 62. Human Embryonic Stem Cells (HESC) Production Process Figure 63. Channels of Distribution (Direct Vs Distribution) Figure 64. Distributors Profiles Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

ESI BIO Thermo Fisher BioTime MilliporeSigma (Merck) BD Biosciences Astellas Institute of Regenerative Medicine Asterias Biotherapeutics PerkinElmer Takara Bio Fujifilm Cellular Dynamics Reliance Life Sciences R&D Systems (Biotrchne) STEMCELL Technologies TATAA Biocenter UK Stem Cell Bank Viacyte, Inc.